Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03117751
Title Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications

acute lymphoblastic leukemia

lymphoblastic lymphoma

Therapies

Cyclophosphamide

Vincristine Sulfate

Idarubicin

Blinatumomab

Doxorubicin

Clofarabine

Vorinostat

Ruxolitinib

Prednisone

Bortezomib

Etoposide

Dasatinib

Daunorubicin

Dexamethasone

Rituximab

Methotrexate

Cytarabine

Mercaptopurine

Pegaspargase

Age Groups: child | adult
Covered Countries USA


No variant requirements are available.